Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Mixed hyperlipidemia (disorder) (Disease Or Phenotype)

Medcin:MEDCIN:311474

Mdr:MDR:10027763

Id:ede38484-ca1f-5dda-8d25-e7206603ed29

Icpc2icd10eng:MTHU010452

Icd10cm:E78.2

Results found

Linked to

	Label	Description
	ciprofibrate indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	cerivastatin indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	atorvastatin indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fluvastatin sodium indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	pitavastatin indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	monacolin K indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	fenofibrate indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pravastatin indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Choline fenofibrate indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

ciprofibrate indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

cerivastatin indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

atorvastatin indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fluvastatin sodium indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

pitavastatin indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

monacolin K indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

fenofibrate indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pravastatin indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Choline fenofibrate indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Mixed hyperlipidemia (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.